Trulieve CEO Sells $1.2 Million in Stock as Shares Jump 148% in One Year

June 27, 2026 - 18:01

The chief executive officer of Trulieve Cannabis Corp. has sold a substantial chunk of company stock, cashing in on a remarkable rally that has seen the company's shares more than double over the past twelve months. According to a recent filing with the U.S. Securities and Exchange Commission, the insider transaction involved the sale of shares valued at approximately $1.2 million.

The sale comes at a time when the vertically integrated cannabis operator has seen its stock price skyrocket by 148% over the last year, a performance that has outpaced many of its peers in the volatile cannabis sector. While insider selling is not uncommon, the size of this particular transaction has drawn attention from market watchers. Investors often scrutinize such moves for signals about management's confidence in the company's near-term prospects.

Trulieve, which operates a significant footprint in Florida and several other states, has been a dominant player in the medical marijuana market. The company has also been expanding aggressively into the adult-use recreational market in states like Pennsylvania and Ohio, where regulatory changes have opened new revenue streams. Despite the strong stock performance, the broader cannabis industry continues to face headwinds, including federal prohibition, high tax burdens, and a fragmented state-by-state regulatory landscape.

The SEC filing did not specify the exact reason for the CEO's stock sale. Such transactions are often part of pre-arranged trading plans or personal financial management strategies. However, the timing of the sale, following a period of intense share price appreciation, has fueled speculation among analysts about whether the stock's current valuation is sustainable. Trulieve has not issued an official statement regarding the insider transaction beyond the required regulatory disclosure.